Press Release Summary:
With submission planning, publishing, viewing, and registration management capabilities, LIQUENT InSightÃ‚Â® v6.0 Regulatory Information Management platform supports entire regulatory product lifecycle, from early planning of registration targets through product retirement. Business Intelligence provides analytics to optimize reporting capabilities, while updated data model helps to ensure that processes, output, and work product comply with standards such as XEVMPD.
Original Press Release:
PAREXEL Launches LIQUENT InSightÂ® 6.0 Regulatory Information Management Platform
BOSTON,Â – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced the latest version of its Regulatory Information Management (RIM) platform: LIQUENT InSightÂ® 6.0. The LIQUENT InSight platform supports the entire regulatory product lifecycle, from early planning of registration targets through product retirement, with robust submission planning, publishing, viewing and registration management capabilities.
While biopharmaceutical companies and the patients who can benefit from new drugs are located throughout the world, there is no single international regulatory body to review and approve new medicine applications.Â For new and innovative medicines to successfully reach patients and maintain regulatory compliance throughout the product lifecycle, biopharmaceutical companies must navigate the complex, global regulatory and region-specific regulations.
"LIQUENT InSight 6.0 simplifies navigation of the global regulatory environment and provides the submission and registration management tools needed to more quickly bring treatments to market and effectively maintain them throughout their lifespan," said Xavier Flinois, President, PAREXEL Informatics. "As an essential part of the drug development journey, the LIQUENT InSight platform centralizes a company's regulatory information to drive standardization, improve collaboration, and helps to ensure compliance, eliminate waste, reduce costs, and increase efficiencies so more patients can quickly and safely receive the treatments they need."
Enhancements to the LIQUENT InSight platform include:
--Â Business Intelligence: added robust analytics to enhance reporting capabilities
--Â Usability: simplified interface designed by usability experts provide an intuitive experience to all levels of InSight users
--Â Compliance: updated data model and architecture helps to ensure processes, output and work product compliance with standards such as XEVMPD and the upcoming IDMP mandate
--Â Interoperability: revamped interoperability web services features that help systems interact and communicate with each other
Since the market introduction of LIQUENT InSight in 2004, more than 40 companies (including 14 of the top 20 pharmaceutical companies) have selected the LIQUENT InSight platform as their single source of regulatory information. PAREXEL's RIM technologies can also be coupled with comprehensive professional services from PAREXELÂ® Consulting, which provides a full complement of Regulatory Outsourcing Services to help companies meet the demands of today's complex and changing regulatory environment.Â LIQUENT InSight 6.0 will also be available through the PerceptiveÂ® Partner Program.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 81 locations in 51 countries around the world, and has approximately 16,530 employees.Â For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL, PAREXEL Informatics, Perceptive, and LIQUENT InSight are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.
PAREXEL InternationalÂ Â Â Â Â Â Â Â Â Â Â
Tel: +1 781-434-5516Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â
Tel.: +1 781-434-4019